4,4',4'',4'''-([2,2'-Bi(1,3-dithiolylidene)]-4,4',5,5'-tetrayl)tetrabenzaldehyde, 97%, 100mg

2-methyl-1,2,3,4-tetrahydroquinoxaline, 95.0%, 250mg

3,4-dihydro-1H-isochromen-3-ylmethanol, 95.0%, 1g

6-Chloropyridine-2,3-dicarboxylic acid dimethyl ester, 95.0%, 10g

2-Hydroxy-6-methoxybenzoic acid, 97.0%, 10g

2-(4-Chlorophenoxy)-1,3-difluoro-5-nitrobenzene, 97%, 1g

Diethylene Glycol Bis(3-aminopropyl) Ether>98.0%(GC)(T)500mL

FMOC-3,5-DIIODO-L-TYROSINE, 95%, 25g

HPTLC Silica Gel 60 GF254, 2.5*7.5cm glass support, 0,25mm coating, binder polyacrylate-Na, 320pcs/box, 320.0ea

2-Bromo-3-fluoro-5-iodotoluene, 97.0%, 1g

1-(2-Bromoimidazo[1,2-a]pyridin-3-yl)ethanone, 97%, 1g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(6-chloro-1H-indol-3-yl)propanoic acid, 97%, 250mg

4-CHLORO-6-METHYL-3-NITROPYRIDIN-2(1H)-ONE, 95.0%, 250mg